364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies
نویسندگان
چکیده
tal General de México, Mexico City, Mexico. Background: Giant papillary conjunctivitis is associated with soft and rigid contact lens wearing, ocular prostheses, exposed sutures, extruded scleral buckle, filtering blebs, band keratopathy, corneal foreign bodies, limbal dermoids, and cyanoacrylate tissue adhesives. Patients present decreased lens tolerance, increased lens movement and awareness, mucus, irritation, redness, burning, and itching. Is bilateral and 10% unilateral. The upper tarsal conjunctiva shows inflammation, papules .0.3 mm, bulbar conjunctival injection, superior corneal pannus or opacities. Fluorescein noted papillary reaction. Histopathology: Mast cells, basophils and eosinophils were found in the epithelium and substantia propia. Histamine, Ig, IgG, IgM, C3, Factor B, C3 anaphylatoxin, Eotaxin, Neutrophilic chemotactic factor elevated in tears. Lactoferrin is decreased. Pathophysiology: The cause is unknown, factors as immunologic disease, mechanical trauma or irritation influence. Contact lenses become coated that serves as an antigen so the increased proteins in the tear film result in further coating. Treatment: Nonsteroidal anti-inflammatory agents, topical mast cell stabilizers or mast cell stabilizer-antihistamines. Replacement lenses at 2 weeks to 3 months. Daily lens disinfection with hydrogen peroxide and unpreserved saline solution. Severe should stop wearing their contact lenses for .4 weeks or refit with rigid gas-permeable lenses. Methods: A 7 year-old female presents 6 months ago redness, pruritus, forgein body sensation, eyelid inflammation without improvement with treatments. On examination with conjunctival hyperemia, hypertrophy of papillae and epiphora.A 22 year-old male presents at 7 years old conjunctival burning, foreign body sensation, conjunctival hyperemia, hyaline secretion treated with topical antibiotics and steroids with minimal and temporal improvement. On examination, conjunctival hyperemia, giant papillae on superior tarsal bilateral predominantly left. Stool negative. Results: We found 2 patients affected without common triggers and early onset of severe clinical manifestations and refractory to usual treatment. Conclusions: We present 2 clinical cases of unusual presentation since both of them were pediatric presentation and Giant papillary conjunctivitis has its peak of incidence in the adult population. Besides, both patients lacked an initial trigger such as contact lens wearing or ophthalmologic surgery. Both of them had a poor response to treatment. This disease should be considered in pediatric population and start treatment inmediately to avoid complications such as loss of vision.
منابع مشابه
367 Evaluation of Allergen Sensitivity in Patients with Contact Dermatitis in Antalya
assess duration of action, patients were challenged with allergen 16 hours after dosing. The percentage of eyes with zero itching in both studies was assessed at 3 minutes post allergen challenge. Results: The percentage of eyes with zero itch at the 3 minutes timepoint after the onset of action allergen challenge was 60.0% for OLO-treated eyes compared with 5.9% for vehicle-treated eyes (P , ....
متن کامل366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
assess duration of action, patients were challenged with allergen 16 hours after dosing. The percentage of eyes with zero itching in both studies was assessed at 3 minutes post allergen challenge. Results: The percentage of eyes with zero itch at the 3 minutes timepoint after the onset of action allergen challenge was 60.0% for OLO-treated eyes compared with 5.9% for vehicle-treated eyes (P , ....
متن کامل365 Patch Testing Results in Contact Dermatitis from the Allergist's Perspective
assess duration of action, patients were challenged with allergen 16 hours after dosing. The percentage of eyes with zero itching in both studies was assessed at 3 minutes post allergen challenge. Results: The percentage of eyes with zero itch at the 3 minutes timepoint after the onset of action allergen challenge was 60.0% for OLO-treated eyes compared with 5.9% for vehicle-treated eyes (P , ....
متن کاملOcular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
INTRODUCTION The efficacy and safety of the once-daily topical ophthalmic solutions, alcaftadine 0.25% and olopatadine 0.2%, in preventing ocular itching associated with allergic conjunctivitis were evaluated. METHODS Pooled analysis was conducted of two double-masked, multicenter, active- and placebo-controlled studies using the conjunctival allergen challenge (CAC) model of allergic conjunc...
متن کاملA multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model
BACKGROUND The purpose of this study was to evaluate the efficacy and duration of action of once-daily dosing with alcaftadine 0.25% ophthalmic solution and olopatadine 0.2% ophthalmic solution as compared with placebo in the prevention of ocular itching, and to directly compare the efficacy of alcaftadine 0.25% with olopatadine 0.2% in the prevention of ocular itching associated with allergic ...
متن کاملTreatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H(1) receptor antagonist action, chemical mediator suppressive action, and eosinophil infiltration suppressive action. Olopatadine hydrochloride 0.1% ophthalmic solution (Patanol((R))) was introduced to the market in Japan in October 2006. In a conjunctival allergen challenge (CAC) test, olopatadine hydro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 5 شماره
صفحات -
تاریخ انتشار 2012